Presenter(s): Daniel Rose, MD, FASAM
Target Audience: This activity is designed for Administrative Staff, Counselors, Interprofessional Teams, Nurses, Pharmacists, Pharmacy Technicians, Physician Assistant, Physicians, Psychiatrists, Psychologists, Social Workers, Students and Educators and Family and Patients. This activity is not accredited.
Webinar Description: Due to the opioid epidemic, over 2.5 million adults in the U.S. have opioid use disorder (OUD), yet only 25% of those who need treatment receive recommended medication for opioid use disorder (MOUD). Alongside the rising rates of OUD, there has been an increase in infectious diseases such as HIV, hepatitis B and C, endocarditis and skin and soft-tissue infections, particularly among people who inject drugs. These intertwining epidemics have not been sufficiently addressed, but MOUD — combined with appropriate substance use treatment supports and health care services — represents an opportunity to reduce risk and improve health outcomes.
Educational Objectives:
- Examine the connection between OUD and infectious disease.
- Discuss increased risk for infections among individuals with OUD.
- Describe the benefits of MOUD and integrated healthcare services in preventing and treating OUD and infectious disease.
- Identify unique barriers and solutions for access to MOUD services and infectious disease care.